# 1. Financial Performance ## A. Key Figures * **Gross Profit:** **₹8,617.82 Lakhs** consolidated (+113.9%) * **Gross Margin:** ~**60%** (up from ~55% YoY) * **EBITDA:** **₹127.58 Lakh** consolidated for Q3FY26 ## B. Revenue Growth * **Modest Top-Line Growth:** Revenue growth remained muted at 2% YoY, driven by store additions and network scale, though inflated by franchise fee recognition unrelated to GMV. * **Revenue-GMV Decoupling:** Franchise model dynamics cause structural divergence between revenue and GMV, with revenue recognized upfront on goods supplied, while GMV lags based on franchisee sell-through. * **Narrowing Gap Trend:** The typical ~40% revenue-GMV gap has narrowed recently due to higher franchisee inventory purchases not yet translating into proportional GMV growth. ## C. Gross Profit * **Margin Expansion:** Gross margin improved ~500 bps YoY to nearly 60%, driven by the increasing contribution from **Davaindia** and operating leverage. ## D. EBITDA Trends * **Margin Pressure from Expansion:** Consolidated EBITDA declined sequentially despite gross profit growth, pressured by pre-opening costs for **over 400 stores** and higher operating expenses. * **Future Margin Guidance:** Mature store-level EBITDA margins expected in the **25–30%** range, with potential for **17–20%** at the company level upon full network maturity. * **EBITDA Definition Clarified:** Reported EBITDA is **pre-rent and pre-Ind AS**, with pre-Ind AS EBITDA separately disclosed for transparency. ## E. Balance Sheet * **Strong Liquidity Infusion:** Balance sheet significantly strengthened via **₹350 Cr QIP**, attracting institutional capital and providing long-term financial flexibility. * **Capital Deployment Focus:** QIP proceeds primarily funding **working capital** and **new store rollouts** under a two-year deployment plan starting April 2026, supporting accelerated expansion. --- # 2. Store Network & Expansion ## A. Key Figures * **New Stores (Q3 FY26):** **276** stores added (total network: **2,331**) * **COCO Stores:** **1,438** total · **355** opened in H1 FY26 * **FOFO Stores:** **893** total * **Annual COCO Target:** **800** stores (586 opened in 9M FY26) ## B. Store Additions * **Accelerated Expansion:** Record store rollout in Q3 with **over 500 COCO stores** added to pipeline, front-loading H2 execution to meet annual target. * **Funding Discipline:** Expansion remains on track despite **reduced QIP proceeds (INR350 Cr)**; strict budget controls in place to prioritize COCO growth. * **Near-Term Momentum:** Current quarter (Jan–Mar) expected to see **70% of remaining 400 stores** opened, supported by **90–120 day setup timeline**. ## C. COCO vs FOFO Mix * **Margin Profile:** COCO stores deliver **25–30% margin** at maturity, while FOFO stores generate **40–45% EBITDA margin** due to asset-light model. * **Store Performance:** Majority of stores profitable after two years; **~15% of 1–2 year-old stores** near break-even, with **2–5% underperforming** (revenues <INR25–5 lakh/month). ## D. Pipeline & Rollout * **Geographic Reach:** COCO presence expanded to **23 states and 5 union territories** in 9M FY26, reflecting broad-based rollout. * **Future Cadence:** Next fiscal year targeting **800–1,000 stores** with **even quarterly distribution (200–250/store/qtr)**, signaling return to steady-state after H2 surge. --- # 3. Customer & Sales Metrics ## A. Key Figures * **Customer Footfall:** **49 lakh** quarterly (Q3FY26) (+81% YoY) · **27 lakh** quarterly (Q3FY25) * GMV: **₹12,172 lakhs** quarterly (Q3FY26) (~+100% YoY, ~5.15% GST impact) * **Store Count:** **~1,400** total stores (~600 added last 3 quarters) ## B. Footfall Trends * **Robust Footfall Growth:** Quarterly customer traffic surged on strong year-on-year and sustained cohort-level momentum, with mature stores driving upside. * **Resilient Store Productivity:** Average daily footfall per store held steady at **28–30 customers** despite aggressive expansion, signaling effective demand absorption. * **Mature Store Strength:** Four-year-old stores delivering **~4% QoQ growth**, implying **15–20% annualized growth**, with no signs of saturation. * **New Store Ramp-Up:** New stores begin with low footfall (**15–20/day**), but performance is offset by rising traffic in established locations. ## C. Wallet Spend * **Stable Unit Economics:** Average wallet spend remains resilient despite network expansion, reflecting consistent customer value perception. * **Positive Spend Trajectory:** New stores show improving wallet spends from initial levels **below ₹200**, indicating favorable maturation trends. * **Like-for-Like Revenue Growth:** First-cohort stores posted higher monthly revenue, with **₹2 lakh/month in Q2**, underscoring real growth beneath GST-related noise. ## D. GMV Performance * **GMV Growth Intact Post-GST Adjustment:** Underlying GMV trends remain strong, with adjusted figures confirming robust like-to-like performance despite reported flattening. * **Franchisee Reporting Drives Variance:** GMV may be understated due to **incomplete/delayed invoicing**, particularly in the **FOFO model**, limiting real-time accuracy. * **Mature Store Revenue Run-Rate:** First-cohort stores generating **~₹7 lakh/month (~₹82 lakh annually)**, still growing at **15–20% YoY**, with potential to exceed **₹1 crore/store/year** if trends persist. --- # 4. Cost Structure & Margins ## A. Key Figures * **Consolidated Employee Costs:** **₹52 Cr** in Q3 (+₹14 Cr QoQ) · **₹38 Cr** in Q2 * **Employee Cost per Store:** **₹80,000–₹85,000** average in Q3 (includes live and non-live) * **Gross Margin:** **66%–67%** (last two quarters), above guided 60% * **Director Remuneration:** **₹60 Lakh/year** (Whole-Time Directors), up ~43% * Commission Expense: ~INR1–1.5 Cr in Q3, up to 2%-3% of total employee costs ## B. Employee Cost Drivers & Expansion Impact * **Pre-Operative Cost Surge:** Elevated employee expenses driven by **aggressive store expansion**, with costs incurred for ~650 stores (including ~400 non-live) during Q3. * **Advance Hiring Necessity:** Staffing for new stores begins pre-launch due to regulatory licensing and training requirements, creating near-term cost drag. * **Cost Normalization Ahead:** Pace of store additions has been **consciously reduced**, with employee costs expected to **moderate in the next quarter** and normalize over 1–2 quarters. ## C. Marketing Spend & Brand Strategy * **Phased Brand Campaign Rollout:** Multi-channel marketing push underway, including **cinema, taxis, and TV** (Suniel Shetty), with **MS Dhoni TVC imminent**. * **Cost-Efficient Execution:** Marketing spend effectively managed via balanced **ATL/BTL mix**, with emphasis on **neighborhood-level BTL impact** and timing optimization. ## D. Margin Trajectory & Store Economics * **Gross Margin Upside:** Sustained **66–67% gross margins** signal pricing power and supply chain efficiency, with **path to 70%** over 4–6 quarters. * **Blended Margin Pressure:** Current EBITDA margin decline reflects **dilution from new COCO store ramp-up**, which carry lower initial margins despite higher gross margins. * **Future Margin Stability:** As store maturity improves and rollout balances, **cost and margin volatility from expansion is expected to decline**. --- # 5. Product & Segment Mix ## A. Key Figures * **Revenue Contribution:** **80%** from Davaindia · **11%** domestic sales · **6%** export sales · **2%** Everyday Herbal Group * **Subsidiary Capital:** **INR 10 lakh** initial paid-up capital for KMHP Ventures Limited ## B. Revenue Contribution * **Dominant Segment:** Davaindia remains the primary revenue driver, significantly influencing overall margin structure and strategic focus. * **Strategic Expansion:** Acquisition of 100% stake in Curexis (brand 'SKIA') bolsters retail generics and specialty pharmacy footprint across pharmaceuticals, nutraceuticals, and OTC segments. ## C. Brand Portfolio * **Brand Building:** DavaIndia’s acquisition of SKIA aims to strengthen affordable healthcare positioning, preempt competition, and scale the generic medicine retail model with distinct consumer experience. * **Marketing Push:** Appointment of high-profile brand ambassadors **Suniel Shetty** and **Mahendra Singh Dhoni** underscores aggressive brand equity building. * **Therapeutic Focus:** Zota Healthcare targeting key chronic and essential care segments—**diabetic, cardiac, gastro, paediatrics, and obstetrics**—across urban and rural India. --- # 6. Risks & Regulatory Factors ## A. Key Figures * **GST Impact:** **~5.15%** reduction in reported GMV due to rate cut from 12% to 5% * **Underlying Performance:** **Volumes and operational metrics show improvement** despite lower GMV ## B. GST Impact * **GMV Distortion:** Reported GMV is materially depressed by the GST cut, masking strong underlying volume growth and business momentum. * **Regulatory Headwind:** The 700 bps reduction in GST rate creates a significant year-on-year reporting headwind, requiring investors to adjust for true performance trends. ## C. Franchisee Reporting * **Inventory Challenges:** Temporary product unavailability at **COCO stores** reflects ongoing optimization, not systemic supply issues. * **Operational Refinement:** Shipment hiccups acknowledged but being resolved through continuous process improvements across the franchise network. --- # 7. Guidance & Outlook ## A. Margin Projections * **Margin Trajectory:** Near-term margin pressure from expansion is transitory, with clear path to margin normalization and improved operating leverage as store network matures. * **Long-Term Margin Potential:** Management affirms EBITDA margin expansion will continue until **2030**, with potential to reach **15%–17%** on existing store base by **FY28–FY29**. * **Conditional High-End Target:** On a same-store basis, **EBITDA margins of 18%–20%** are achievable in **2–3 years**, though contingent on halting new store openings. * **No Revenue Guidance:** Management refrains from providing revenue or EBITDA guidance for FY27–FY28 due to aggressive expansion phase, but offers detailed store-level data for investor modeling. ## B. Expansion Targets * **Ambitious Store Rollout:** Strategic objective to surpass **5,000 Davaindia stores by March 2029**, supported by QIP funding and cash flow from maturing locations. * **Funding Self-Sufficient:** QIP proceeds fully cover funding needs for **FY26–27 and FY27–28**, with no external capital expected during this period. * **Expansion Pace Unchanged:** No reduction in FY27 target of **1,000 new stores**; pace remains aligned with long-term network buildout.